ruffrecords said:I think is was Harold Wislon who said two weeks is a long time in politics. It was not that many weeks ago that von der Leyen was *****ing about Astra Zeneca (manufacturers of the Oxford vaccine) not being able to supply the number of vaccines in the timescale agreed and she was hell bent on getting them no matter who they were destined for.
Now both Germany, Belgium and France report they are having trouble getting people to have the jab. They have plenty of stock. People are just not turning up for their appointments. according the Macron the Oxford vaccine has an 'image' problem and they are planning an advertising campaign to get more people vaccinated.
Cheers
Ian
You are quite right. I saw all three countries referenced in a single article but Belgium was not one having problems convincing people to have the vaccine. My apologies.cyrano said:That's certainly false for Belgium.
Interesting. Nigel Farage (Mr Brexit himself) decamped to Japan soon after the Covid outbreak. He wrote about it in an article. From what I rememeber he seemed to be saying he thought he would be safer there if only because of the cultural attitude of obedience to rules. I bet he is regretting that choice now that all Brits at home of his age have received at least one vaccination.Script said:Yesterday, a Japanese newspaper reported that a total of 4008 health care professionals have been inoculated here within 24 hours. Wow, I thought. Japan has a population of 126M, so at that rate it'll take them only 87 years to vaccinate everybody. Guess that's what happens when ordering jabs late... ...
Oh, thanks for that info. I didn't know that. That's funny. I mean that really funny. LOL. Brilliant ! ;D ;DInteresting. Nigel Farage (Mr Brexit himself) decamped to Japan soon after the Covid outbreak
cyrano said:That's pretty strange.
We don't see that over here. No rise in infections in the 0-9 year age range. The number of infections is very low, the number of sick children due to Covid is next to zero, excluding those who were sick before getting infected. That last group doesn't even show in the numbers, as there's only a few dozen on a population of around 11 million.
The French ministry of health and social affairs announced Monday that among a cluster of 79 COVID-19 cases in Brittany, eight patients were infected with the new variant, but several of them tested negative.
Despite those negative tests, the patients showed typical COVID-19 symptoms.
Virus-virus interactions influence the epidemiology of respiratory infections. However, the impact of viruses causing upper respiratory infections on SARS-CoV-2 replication and transmission is currently unknown. Human rhinoviruses cause the common cold and are the most prevalent respiratory viruses of humans. Interactions between rhinoviruses and co-circulating respiratory viruses have been shown to shape virus epidemiology at the individual host and population level. Here, we examined the replication kinetics of SARS-CoV-2 in the human respiratory epithelium in the presence or absence of rhinovirus. We show that human rhinovirus triggers an interferon response that blocks SARS-CoV-2 replication. Mathematical simulations show that this virus-virus interaction is likely to have a population-wide effect as an increasing prevalence of rhinovirus will reduce the number of new COVID-19 cases.
Enter your email address to join: